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THE FUTURE OF ENZYME RESEARCH 
The Fourth Edsel B. Ford Lecture, 1955 
LINUS PAULING* 
I am honored to have been invited to speak at this great International Symposium 
on Enzymes, and especially to be allowed to give a talk with the title The Future of 
Enzyme Research. This title suggests that I think that I know enough about the 
subject of enzymes to extrapolate its course into the future—I do not—or that I 
have a scientific crystal ball that I can look into—1 do not. What I do have is a deep 
belief about the importance of enzymes as subjects for investigation, and a sincere 
admiration for enzyme chemists and biologists; and I am happy to be associated 
with them, even if only in the peripheral capacity of an after-dinner speaker. 
The problem of enzymes encompasses essentially the whole of biology. When 
we understand enzymes—their structure, the mechanism of their synthesis, the 
mechanism of their action—we shall understand life, except for those aspects of life 
that involve mental processes; and I have no doubt that enzymes are important for 
these too. 
Enzymes do an extraordinary job—that of causing chemical reactions to take 
place in the body, at body temperature, which without enzymes can be made to 
take place only under much different conditions or with great difficulty. The out-
standing characteristic of enzymes is their specificity. For example, the enzyme 
/:?-galactosidase is able easily to hydrolyse a galactoside, whereas it has little effect on 
the hydrolysis of a glucoside, which differs from the galactoside only in the spatial 
configuration about a single carbon atom. 
The specificity that is shown by enzymes in their activity is not unique to these 
substances. It is found also in the ability of antigens to produce specific antibodies, 
in the action of drugs and hormones, and in the action of genes in producing replicas 
of themselves and in serving also to produce other substances of well-defined structure. 
Of the various molecules that demonstrate specificity in their physiological activity, 
genes are the best. Antibodies are heterogeneous—they have the power of reacting 
not only with the antigen that caused their manufacture, but also with other antigens, 
more or less closely similar to the original one; enzymes may serve to catalyze re-
actions involving several different, somewhat related, substances; but genes seem to 
be nearly perfect in their action. 
It is easy to understand why genes come closer to perfection than the other 
molecules with specific biological activity—there is an automatic mechanism for 
making genes better.^  The manufacture of an antibody molecule is a process that 
occurs only once, so far as that molecule is concerned. I think that in the manu-
facture of an antibody molecule the antigen serves as the template, the antibody being 
molded about it. If the conditions under which the antibody molecule is being manu-
factured be such as to favor the formation of a good molecule, with high comple-
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mentariness to the antigen molecule, the resulting molecule will be highly specific 
in its activity—it will be able to combine very strongly with the homologous antigen, 
and much less strongly with other molecules; but if conditions are unfavorable (in-
cluding the operations of chance during the process of synthesis of the molecule) 
the antibody molecule that is formed may have only small power of combining with 
this antigen, and a greater power of combining with other molecules. There is no 
process of selection that operates to improve the quality of the antibody molecules that 
are manufactured with use of the injected antigen as the template. The process of 
duplication of genes is different in nature: it permits a search to be made for a. 
molecular structure with improved power of reduplication. Let us consider, as an 
example, a gene that has undergone mutation. This molecule, which we may call A i , 
serves as a template for the manufacture of a complementary molecule, Bi. 
This molecule, Bi, may then serve as the template for the manufacture of another 
molecule, A j , complementary to Bi and similar to Ai . By repetition of this process 
the series of molecules, each complementary to the preceding one, is continued: B2, 
A3, B3, A4, B4, . . . If at any time in this process a molecule A N happens to be formed 
that is perfectly suited to serving as the template in the two-stage manufacture of a 
duplicate of itself, the process of duplication from then on would be a perfectly re-
liable one. In this way, the mechanism of heredity permits the ultimate discovery 
of a gene with the power of duplicating itself perfectly; or perhaps of a gene with such 
a structure that the process of duplication, if not perfect, is quickly self-correcting. 
In the above discussion we have assumed that biological specificity is the result 
of complementariness in structure, rather than identity in structure. Each of these two 
alternatives has its appeal. The idea that there are special forces that operate between 
identical molecules has been suggested to a number of investigators by the resonance 
phenomenon in quantum mechanics. It seems likely that the specific forces resulting 
from this phenomenon, operating between identical molecules, are so weak as to be 
negligible, in the case of large molecules such as proteins and nucleic acids.' There is 
no doubt whatever that the specificity of the interaction of antibodies and antigens is 
due to a detailed complementariness in surface configuration and structure that 
permits the antibody molecule and the antigen molecule to come into close contact 
(to within about 1 A of the minimum distance of approach) over a surface area 
approximately 100 A^ and that the integrated weak forces of van der Waals at-
traction, coulomb attraction between positively charged and negatively charged groups, 
and hydrogen-bond formation between complementary hydrogen donors and acceptors 
leads to a specific bond of significant strength between the complementary molecules. 
I think that complementariness in molecular structure of the same sort is responsible 
for biological specificity in general. In particular, I think that it is likely that many 
enzymes—perhaps all enzymes except those involved in the transfer of electrons 
during oxidation-reduction reactions—are effective because of a complementariness 
in structure to the reacting molecules. By the "reacting molecules" I do not mean 
the substrate molecules themselves, with their normal configurations. I f an enzyme 
were to have a structure complementary to that of the substrate molecules in their 
normal configurations, the combination of the substrate molecule with the enzyme 
would stabilize the system, and in this way would increase the energy of activation 
associated with the reaction, and hence decrease the speed of the reaction. If , however. 
the enzyme were complementary in structure to the activated complex—the half-
way structure in the chemical reaction—and not to the reactant molecules or the 
product molecules, then the energy of interaction of the enzyme with the activated 
complex would decrease the energy of activation, and hence increase the speed of 
the reaction. This is a reasonable picture of enzymic activity, and one that is supported 
by experimental information about inhibition of enzyme reactions. We see that a 
molecule of an excellent inhibitor of an enzyme is one that simulates in its structure 
the activated complex. By the continued study of inhibition of enzyme reactions 
and determination of the detailed molecular structure of the inhibitors it may be 
possible to reach some reliable and detailed conclusions about the structure of the 
enzyme itself, in the region carrying the activity. 
In order to increase our knowledge of the structure and mechanism of action of 
enzymes more work must be done in the field of molecular structure. In particular, 
the present structure theory of chemistry, which applies in the main to substances 
in their normal states, must be extended to cover also the activated complexes. Be-
cause of the brief period of time during which the activated complexes exist, in the 
course of chemical reactions, the experimental study of their structure is difficult. 
I think that it is likely that the development of the field of structural chemistry of 
activated complexes will be made in large part through the application of theory—an 
extrapolation from the chemical structure theory of substances in their normal states. 
Enzymology as a science now stands where organic chemistry stood a century 
ago, before the structural formulas of chemistry were developed. In the course of 
the many interesting papers about enzymes that were presented at the symposium 
today there was not shown a single lantern slide giving the interatomic interrelation-
ships of an enzyme and the activated complex for the catalyzed reaction. The time 
is rapidly approaching when enzyme chemists will use structural formulas of activated 
complexes, and structural formulas of the enzymes with all interatomic dimensions 
correct; when this time comes, enzymology will have reached the stage in its develop-
ment that has now been reached by organic chemistry. 
Enzymes are proteins. During recent years we have seen the astounding develop-
ment of chemical methods, including chromatography, to such power as to permit 
the determination of long sequences of amino acids in the polypeptide chains of 
proteins. It is evident, however, that an understanding of the specific properties of 
proteins cannot be obtained through knowledge of amino-acid sequences alone. It 
will also be necessary to have knowledge of the way in which the polypeptide chain 
is folded, and the detailed configuration in space of the side chains. I am confident 
that the x-ray investigation of crystals of globular proteins will be successful in leading 
to the complete structure determination—the location of every atom—of the molecules 
of many proteins long before the next fifty years of enzyme research is over. I am 
willing to forecast that within ten years there will have been made such a complete 
structure determination of at least one crystalline globular protein. 
It is hard to forecast to how great an extent enzyme research during the next 
fifty years will lead to progress in the field of medicine. It is now known that a 
number of diseases are the result of some sort of abnormality involving enzymes, and 
that perhaps these diseases should be described as molecular diseases, resulting 
from the synthesis of enzymes of abnormal structure, which are not able to carry 
out in a proper way the work that the enzyme normally does. Sickle cell anemia was 
the first disease to be recognized as resulting from the gene-controlled synthesis 
of an abnormal molecule, in this case the hemoglobin molecule. It has been shown 
that a condition that may be called a disease occurs in Neurospora as a result of 
the manufacture of abnormal molecules of the enzyme tryptophan synthetase. The 
disease phenylketonuria, which leads to mental deficiency and other manifestations, 
seems clearly to be the result of a gene-controlled failure of the individual to manu-
facture an effective enzyme that normally catalyzes the process of oxidation of 
phenylalanine to tyrosine. Perhaps the genie abnormality is such as to lead to a 
complete interruption of the process of manufacturing this enzyme, or perhaps an 
abnormal molecule is manufactured, which does not have the normal enzymic activity. 
A score of diseases have so far been recognized as enzyme diseases, presumably 
resulting from the manufacture of abnormal molecules in place of the active enzyme 
molecules. I think that it is not unlikely that there are hundreds or thousands of 
such diseases. 
I foresee the day when many of these diseases will be treated by the use of 
artificial enzymes. When our understanding of enzyme activity becomes great enough, 
it will be possible to synthesize a catalyst for the oxidation of phenylalanine to 
tyrosine. A small amount of this catalyst may then be attached to a reticular frame-
work inside of a small open-ended polythene tube, which can be permanently placed 
within an artery of a new-born child who has been shown by the presence of 
phenylpyruvic acid in the urine to have inherited phenylketonuria; through the action 
of the catalyst the child should then develop in a normal way. This idea seems 
fantastic now; but the world of 1955 is a fantastic world from the viewpoint of 1905, 
and I have little doubt that my prediction about the world of 2005 will turn out 
not to be a bold one, but rather a timid and unimaginative one. 
Enzymes are wonderful substances—they consist of wonderful molecules. We 
do not know very much about these molecules as yet, and so far during this Inter-
national Symposium on Enzymes there has been very little discussion of the new 
experimental information about enzymes in relation to the detailed molecular structures 
of the enzymes and the reacting molecules. I am sure that the field of enzyme re-
search will be much different even fifteen years from now—that there will then 
be much greater knowledge than we now have of structure and activity of enzymes. 
I hope that fifteen years from now there will be another international symposium 
on enzymes here in Detroit, and that I may have the opportunity to attend it—and 
I predict that many of the speakers at this symposium, in 1970, will illustrate their 
papers by the use of slides showing detailed molecular structures of enzymes and 
reacting molecules. 
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